YUNPENG XU

Dr. YUNPENG XU

Rutgers, New Brunswick, New Jersey, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
JFJialin Fan
Jialin Fan
YXYUNPENG XU
YUNPENG XU
Dietary restriction (DR), defined as reduced caloric intake or selective limitation of specific nutrients without malnutrition, is one of the most robust interventions known to extend lifespan and healthspan across species. Studies from yeast to mammals demonstrate that DR elicits conserved genetic, transcriptional, and epigenetic programs that promote cellular maintenance and stress resistance. At the molecular level, DR engages evolutionarily conserved nutrient-sensing pathways, including insulin/IGF-1 signaling (IIS), the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and NAD + -dependent sirtuins, which converge on key transcription factors (TFs) and transcriptional coactivators (TCs) to coordinate metabolic and longevity-associated gene expression. Downstream, these pathways enhance autophagy and proteostasis, remodel mitochondrial function and redox balance, reshape immune and inflammatory networks, and induce epigenetic and transcriptional reprogramming. Recent work further highlights amino acid–specific sensing mechanisms, endocrine mediators such as fibroblast growth factor 21 (FGF21), the gut microbiome, circadian regulators, and nuclear pore–associated transcriptional plasticity as integral components of DR responses. Importantly, the physiological outcomes of DR are context dependent and influenced by genetic background, sex, age at intervention, and the type and duration of restriction. In this review, we summarize current knowledge on the genetic and molecular architecture underlying DR-induced longevity and health benefits across species, discuss implications for aging-related diseases, and outline future directions toward precision nutrition and safe translational strategies.

31 July 2025 in Muscles
Verified
Journal Article
Open access
PDF file
JFJialin Fan
Jialin Fan
ZKZara Khanzada
Zara Khanzada
YXYUNPENG XU
YUNPENG XU
Skeletal muscle aging and related diseases are characterized by progressive loss of muscle mass, strength, and metabolic function. Central to these processes is mitochondrial dysfunction, which impairs energy metabolism, redox homeostasis, and proteostasis. In addition, non-mitochondrial factors such as muscle stem cell exhaustion, neuromuscular junction remodeling, and chronic inflammation also contribute significantly to muscle degeneration. This review integrates recent advances in understanding mitochondrial and non-mitochondrial mechanisms underlying muscle aging and disease. Additionally, we discuss emerging therapeutic approaches targeting these pathways to preserve muscle health and promote healthy aging.

15 March 2019 in EMBO Reports
Verified
Journal Article
Open access
PDF file
YXYUNPENG XU
YUNPENG XU
ZHZhidong He
Zhidong He
MSMengjiao Song
Mengjiao Song
YZYifei Zhou
Yifei Zhou
YSYidong Shen
Yidong Shen
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

25 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JFJialin Fan
Jialin Fan
ZKZara Khanzada
Zara Khanzada
YXYUNPENG XU
YUNPENG XU
Skeletal muscle aging and related diseases are characterized by progressive loss of muscle mass, strength, and metabolic function. Central to these processes is mitochondrial dysfunction, which impairs energy metabolism, redox homeostasis, and proteostasis. In addition, non-mitochondrial factors such as muscle stem cell exhaustion, neuromuscular junction remodeling, and chronic inflammation also contribute significantly to muscle degeneration. This review integrates recent advances in understanding mitochondrial and non-mitochondrial mechanisms underlying muscle aging and disease. Additionally, we discuss emerging therapeutic approaches targeting these pathways to preserve muscle health and promote healthy aging.

28 July 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
JFJialin Fan
Jialin Fan
GZGuimei Zhang
Guimei Zhang
SSShuo Sun
Shuo Sun
XZXiaowen Zhang
Xiaowen Zhang
YLYaping Li
Yaping Li
YXYUNPENG XU
YUNPENG XU
Aging is a multifactorial biological process driven by the progressive decline of cellular and tissue homeostasis. Increasing evidence has identified microRNAs (miRNAs) as key epigenetic regulators that fine-tune gene expression networks involved in aging and lifespan determination. Across model organisms—including Caenorhabditis elegans, Drosophila melanogaster, and mammals—numerous miRNAs exhibit age-dependent expression patterns and modulate longevity by targeting conserved signaling pathways such as insulin/IGF-1 signaling, mTOR, autophagy, mitochondrial homeostasis, and inflammatory responses. These small non-coding RNAs function as network regulators that coordinate multiple biological processes underlying organismal aging. In addition to regulating intrinsic aging pathways, miRNAs have emerged as important mediators of environmental longevity interventions. Moreover, dietary restriction (DR), one of the most robust and evolutionarily conserved lifespan-extending interventions, reshapes miRNA expression programs that control metabolic adaptation, stress resistance, and nutrient-sensing pathways. Furthermore, accumulating evidence indicates that circulating miRNAs detected in body fluids—including blood, serum, and urine—may serve as minimally invasive biomarkers for biological aging and age-related diseases. In this review, we summarize current insights into the roles of miRNAs in lifespan regulation across model organisms, discuss their involvement in DR-mediated longevity, and highlight their emerging applications as diagnostic biomarkers and potential therapeutic targets. Finally, we discuss future directions emphasizing integrative multi-miRNA regulatory networks and miRNA-based aging clocks, which may provide new opportunities for understanding aging mechanisms and developing strategies to promote healthy longevity.

7 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
YXYUNPENG XU
YUNPENG XU
JFJialin Fan
Jialin Fan
ZKZara Khanzada
Zara Khanzada
Skeletal muscle aging and related diseases are characterized by progressive loss of muscle mass, strength, and metabolic function. Central to these processes is mitochondrial dysfunction, which impairs energy metabolism, redox homeostasis, and proteostasis. In addition, non-mitochondrial factors such as muscle stem cell exhaustion, neuromuscular junction remodeling, and chronic inflammation also contribute significantly to muscle degeneration. This review integrates recent advances in understanding mitochondrial and non-mitochondrial mechanisms underlying muscle aging and disease. Additionally, we discuss emerging therapeutic approaches targeting these pathways to preserve muscle health and promote healthy aging.